Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04220970

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incide…

Belgium150 participantsStarted 2017-06-07

Treatment: BIA-ALCL

All recent trials (3 shown)

Active — Not RecruitingPhase 1/2

NCT06035497

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With R…

The purpose of this study is to test the safety, tolerability, efficacy, and drug levels of BMS-986369 (Golcadomide) in participants with relapsed or refractory…

Japan85 participantsStarted 2023-11-20

Treatment: BMS-986369

UnknownNot Applicable

NCT05017337

Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular Contracture

BASILICA is a UK NIHR Biomedical Research Centre funded study recruiting patients at The Royal Marsden NHS Foundation Trust. The study aims to obtain blood and…

United Kingdom100 participantsStarted 2021-07-27